Restricts the authority to inject neuromodulators derived from Clostridium botulinum and dermal and soft tissue fillers to certain medical professionals. (BDR 40-677)
Bill status
signed
all 5 stages cleared
Introduction
Feb 2017
Committee Review
May 2017
Senate Passage
May 2017
Assembly Passage
May 2017
Signed into Law
May 2017
Introduced Feb 3, 2017
Signed May 31, 2017
Floor votes · Assembly May 22, 2017
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
23
Key actions
6
Committee
2
May 31, 2017
Signed into law
Approved by the Governor. Chapter 238.
executive
May 23, 2017
Upper · Passed
Assembly Amendment No. 666 concurred in. To enrollment.
upper
May 22, 2017
Lower · Passed
Read third time. Passed, as amended. Title approved. Preamble adopted. (Yeas: 30, Nays: 11, Excused: 1.) To Senate.
lower
May 17, 2017
Lower · Passed
From committee: Amend, and do pass as amended.
lower
Apr 25, 2017
Upper · Passed
Read third time. Passed, as amended. Title approved, as amended. Preamble adopted, as amended. (Yeas: 21, Nays: None.) To Assembly.
upper
Apr 10, 2017
Upper · Passed
From committee: Amend, and do pass as amended.
upper
Feb 3, 2017
Introduced
Prefiled. Referred to Committee on Health and Human Services. To printer.
upper
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 101
Scope: NV
Hi! I can help you understand SB 101. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline